MALVERN, Pa.--(BUSINESS WIRE)--Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company, announced today that it received Frost & Sullivan’s 2007 Growth Strategy Leadership Award in the U.S. Bone Graft Substitute Market.
MALVERN, Pa.--(BUSINESS WIRE)--Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company, announced today that it received Frost & Sullivan’s 2007 Growth Strategy Leadership Award in the U.S. Bone Graft Substitute Market.
